High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma

Abstract

Clinical stage associated with pretreatment absolute values of CA125 should be considered as prognostic factor in EOC patients. Values of CA125 higher than 500 U/mL in high grade serous carcinoma with FIGO stage III resulted in an enhanced survival rate of the patients.